Nektar Therapeutics | NKTR - Ebitda


Nektar Therapeutics reported $-38.9M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Agios Pharmaceuticals USD -108.66M 11.65M Mar/2026
ALKERMES USD 139.22M 58.96M Jun/2026
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Amgen USD 3.86B 1.28B Mar/2026
Baxter International USD 309M 756M Mar/2026
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
Biogen USD 649.7M 76.5M Mar/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Cipla INR 14.03B 4.48B Jun/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Eisai JPY 34.15B 34.48B Jun/2026
Eli Lilly USD 10.29B 1.86B Mar/2026
Exelixis USD 255.4M 2.89M Jun/2026
Gilead Sciences USD 3.51B 489M Mar/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Grifols EUR 482.04M 7.04M Sep/2025
Halozyme Therapeutics USD 328.81M 109.24M Jun/2026
Incyte USD 778.57M 410.6M Jun/2026
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
MacroGenics USD -30.2M 52.15M Mar/2026
Merck USD -1.54B 7.84B Mar/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Neurocrine Biosciences USD 193.3M 25.1M Mar/2026
Novartis USD 6.48B 1.19B Jun/2026
Pfizer USD 6.01B 18M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sarepta Therapeutics USD 375.48M 627.68M Mar/2026
Takeda JPY 364.46B 214.21B Jun/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026
Xencor USD -34.63M 86.74M Jun/2026